🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT00794001
Recruiting Not applicable

Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction

NCT00794001 · tracked via the Priya Life Science Germany tracker
Sponsor
Karl Heinrich Scholz
Phase
Not applicable
Started
2007-10
Last updated
2023-03-30

Condition(s) studied

Myocardial Infarction

Investigational drug(s) / intervention(s)

Data analysis and Feedback

Data analysis and Feedback: Data analysis feedback: quarterly meetings with all stakeholders to present data and discuss potential areas of improvement.

Study summary

Part I (Pilot Phase): The purpose of this study is to examine if formalized data assessment and systematic feedback improves treatment times (i.e. contact-to-balloon time and door-to-balloon time) in patients with myocardial infarction with ST-segment elevation (STEMI).

Part II (Implementation Phase): The Purpose is to prospectively investigate if survival can be improved by stringent use of this concept of formalized data analysis and systematic feedback of procedural and clinical data to all participating physicians and other members of the STEMI patients treating personnel.

Part III (Advance Phase): The purpose is to develop, introduce and evaluate prospectively an automated, highly standardized feedback tool informing participating centers on key performance characteristics (procedural and clinical outcomes).

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * all patients who received a diagnosis of STEMI\* and were transported to the cardiac catheterization laboratory of the primary PCI center with the intention to perform primary PCI. * STEMI definition: * elevation of the ST-segments of greater than or equal to 0.1 mV in at least two contiguous limb- or precordial leads * new or presumable new left bundle branch block in the presence of typical symptoms Exclusion Criteria: * STEMI-patients with duration of infarct-related symptoms longer than 24 hours are excluded

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
St.Bernward Hospital Hildesheim Lower Saxony Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT00794001 on ClinicalTrials.gov ↗ ← All trials in Germany